Advertisement

Topics

STAT Plus: French drug maker Servier sets up U.S. headquarters in Boston’s Seaport

13:40 EDT 10 May 2019 | STAT

Servier Pharmaceuticsla focuses on developing potential cancer-fighting drugs that Servier Group bought from Shire last year for $2.4 billion.

Original Article: STAT Plus: French drug maker Servier sets up U.S. headquarters in Boston’s Seaport

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: French drug maker Servier sets up U.S. headquarters in Boston’s Seaport"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...